
Cyclic melanocortin analog
PT-141
2 sizes · 2 mg–5 mg
- Availability
- In stock
- Documentation
- COA issued per lot
Every order ships with the certificate of analysis for the lot you receive.
Look up a lotDemonstration data. Catalog records, prices, and lot numbers are labelled placeholders. Nothing here is an offer for sale.
What this means
NLR-3504
Formulated solution
Adding to the cart does not place an order. Checkout produces an order request that is reviewed against buyer qualification before anything is accepted or charged.
Reference configuration. Pack sizes are pending supplier confirmation.
Combines an approved-drug active with an unapproved delivery form. Both halves need clearing independently.
Northlake issues the documentation set against the released lot. Because this is a formulated preparation rather than a single substance, the specification has to cover the complete composition, not the active alone.
A formulated mixture has no single formula or mass. Chemistry published here would describe the active alone, not the product.
Every row states where its value came from. Values still pending supplier verification are shown muted and are excluded from this page’s structured data, so nothing unverified is published to search engines either.
| Catalog number | NLR-3504 |
|---|---|
| Canonical identity | Formulated bremelanotide solution — composition pendingPending verificationName identity only. The supplied form is pending on the supplier record. |
| Material type | Formulated drug-active spray |
| Physical form | SolutionPlaceholder |
| Purity | Pending — method and acceptance criteria not yet suppliedPending verification |
| CAS number | Pending — CAS not confirmed for the supplied formPending verification |
| Solubility | Pending — solubility data required from the supplier recordPending verification |
How to read these specifications
Certificates of analysis are issued per lot, so the certificate you receive describes the material you receive rather than a representative batch. Safety data sheets and specification sheets are product-level.
| Document | Lot | Access |
|---|---|---|
| Product specification | — | Request document |
| Safety data sheet | — | Request document |
No lot-matched certificate is published for this record yet, which is why none is listed above. Lot lookup is at /coa.
Storage conditions are taken from the approved supplier specification or the safety data sheet. They are never estimated, which is why they read as pending until that document is on file.
| Storage | Pending — storage is taken from the approved supplier specification or SDS, never estimatedPending verification |
|---|---|
| Laboratory handling | Laboratory material. Handle with appropriate personal protective equipment and consult the safety data sheet before first use.Placeholder |
| Catalog line | Research Reagents |
| Category | Melanocortin Analogs |
| Last reviewed | Jul 31, 2026 |
Not released for supply
Held pending regulatory verification. Published as a reference entry only.
For laboratory research use only. Not for human or veterinary use, not for diagnostic or therapeutic use, and not for food or cosmetic use.
Orders from this line ship to qualified institutional or business accounts only. Account qualification is reviewed before an order is accepted.
HOLD — approved-drug active plus unapproved delivery form

Cyclic melanocortin analog
2 sizes · 2 mg–5 mg

Formulated peptide solution
2 sizes · 15 mL–30 mL

Formulated topical solution
2 sizes · 15 mL–30 mL